This volume evaluates the clinical patterns of resistance to sorafenib, the impact of trial design in the second-line setting and the current gold standard to define radiological resistance; describes the molecular mechanisms responsible for treatment resistance in HCC patients, including components of the immune system and tumor microenvironment; determines the role of the cancer stem cell phenotype in resistance; reviews the experimental models to study resistance; and addresses new approaches to overcome resistance to sorafenib, using successful examples from other malignancies.

This issue of PET Clinics focuses on Gynecologic Oncology, and is edited by Drs. Drew Torigian and Domenico Rubello. Articles will include: The role of CT and MRI in gynecologic oncology; The utility of ultrasonography in gynecologic oncology; FDG-PET assessment of cervical cancer; FDG-PET assessment of ovarian cancer; FDG-PET assessment of other gynecologic cancers; The role of PET imaging in gynecologic radiation oncology; The utility of non-FDG PET in gynecologic oncology; Normal variants and pitfalls encountered in PET assessment of gynecologic malignancies; The role and future of quantitative imaging assessment in gynecologic oncology; Emerging molecular imaging techniques in gynecologic oncology; and more!

Get a quick, expert overview of the many key facets of pediatric cancer genetics with this concise, practical resource by Drs. Nathaniel H. Robin and Dr. Nathaniel H. Robin and Meagan Farmer, MS, CGC, MBA. Ideal for pediatric oncologists and all providers who care for children with cancer, this easy-to-read reference addresses the remarkable potential of genetic testing as well as the complexities of choosing the correct test, understanding the results, and counseling the family. Features a wealth of information on pediatric cancer genetics, including the epidemiology and biology of cancer and the genetic evaluation process and role of genetic counsellors Highlights examples of syndromes that present in childhood and increase susceptibility to cancer Discusses the genetic evaluation process in context of the multidisciplinary care of children with cancer Considers the ethical and legal issues of genetic testing in children and provides illustrative case examples Consolidates today's available information and guidance in this timely area into one convenient resource Features a wealth of information on pediatric cancer genetics, including the epidemiology and biology of cancer and the genetic evaluation process and role of genetic counselors. Highlights examples of syndromes that present in childhood and increase susceptibility to cancer. Discusses the genetic evaluation process in context of the multidisciplinary care of children with cancer. Considers the ethical and legal issues of genetic testing in children and provides illustrative case examples. Consolidates today's available information and guidance in this timely area into one convenient resource.

This book highlights the role of the Translationally Controlled Tumor Protein (TCTP) in cell signaling, cell fate and the resulting connection to disease development. It begins by discussing the structure/function of TCTP, before exploring its role in different species ranging from plants to Drosophila and covering fields such as development, the cytoskeleton, cell division, DNA fragility and apoptosis. In turn, the book's final section is devoted to the role of TCTP in disease, namely asthma and diverse cancers, and ultimately as a target for the treatment of malignancies. What is the common denominator between all these processes and why is TCTP necessary in order for them to occur, even in the worst case such as cancer? The book seeks to provide meaningful answers to this and other key questions. Presenting a broad and revealing view on the topic, it offers an informative guide for scientists and students alike.

Advances in Cancer Research, Volume 137, the latest release in this ongoing, well-regarded serial provides invaluable information on the exciting and fast-moving field of cancer research. This volume presents original reviews on research bridging oncology and gene expression, with this volume covering unconventional approaches to modulating the immunogenicity of tumor cells, tumor dormancy and immunoediting, the emerging role of anti-apoptotic Bcl-2 family proteins in chemoresistance, Beclin-1 and autophagy, MDA-7/IL-24, and nanotechnology and medicine.

Peptidomics of Cancer-Derived Enzyme Products, Volume 42, the latest in The Enzymes series, is ideal for researchers in biochemistry, molecular and cell biology, pharmacology, and cancer, with this volume featuring high-caliber, thematic articles on the topic of peptidomics of cancer-derived enzyme products. Specific chapters cover Circulating peptidome and tumor-resident proteolysis, Colon tumor secretopeptidome, Chemoenzymatic method for glycomics, Human plasma peptidome for pancreatic cancer, Lipoproteomics and quantitative proteomics, Salivaomics: Protein markers/extracellular RNA/DNA in saliva, and Enzyme-responsive vectors for cancer therapy.

This classic text offers a comprehensive, yet concise and manageable overview of oncology nursing. This edition expands on the previous edition by pulling out the symptom management subjects into their own unit. Also includes over 400 multiple-choice review questions for each chapter case study to promote effective content review as well as OCN (R) and AOCN (R) certification preparation. Comprehensive yet concise overview of oncology nursing Consistent format in disease chapters for quick access and understanding of key information Review questions with answers and rationales at the end of each chapter New chapter on Functional Status and its effect on patient outcomes New chapter on Ethical Considerations for the oncology nurse New chapters on Skin Integrity, Oral Mucositis, Bone Marrow Suppression New chapter on Palliative Care offers information regarding providing physical and emotional comfort to dying patients and their families New chapters on Patient Education and Family Caregiving for information on assisting families that provide needed health services and support outside of the healthcare setting New Symptom Management unit with new chapters on Dyspnea, Sleep Disturbance, Nausea, and Hot Flashes Case studies at the end of each chapter correspond with chapter content and review questions with rationales

This book highlights the latest research presented at the International Conference on Translational Medicine and Imaging (ICTMI) 2017. This event brought together the world's leading scientists, engineers and clinicians from a wide range of disciplines in the field of medical imaging. Bioimaging has continued to evolve across a wide spectrum of applications from diagnostics and personalized therapy to the mechanistic understanding of biological processes, and as a result there is ever-increasing demand for more robust methods and their integration with clinical and molecular data. This book presents a number of these methods.

This issue of Otolaryngologic Clinics, guest edited by Dr. Maie St. John, is devoted to Multidisciplinary Approach to Head and Neck Cancer. Articles in this issue include: It Takes a Village - The Import of Multidisciplinary Care; The Role of the Patient: Shared Decision Making; A Story in Black and White: Radiologic Evaluation in the Multi-Disciplinary Setting; Beyond the Glass Slide: Pathology Review in the Multi-Disciplinary Setting; Surgical Innovations; It Takes Two - One Resects, One Reconstructs; Advances in Radiation Oncology: What to Consider; Precision Medicine: Genomic Profiles to Individualize Therapy; The Role of Systemic Treatment Before, During, and After Definitive Treatment; Decision Making for Diagnosis and Management: A Consensus Comes to Life; On Pain; Psychosocial Distress and Screening; First We Eat, Then We Do Everything Else: Nutrition; Functional Assessment and Rehabilitation: How to Maximize Outcomes; Survivorship - Morbidity, Mortality, Malignancy; and Immunotherapy: Who is Eligible?

This issue of Dermatologic Clinics, guest edited by Drs. Darrell S. Rigel and Aaron S. Farberg, is devoted to Non-Invasive Technologies for the Diagnosis of Skin Cancer. Articles in this issue include: Current state and issues of clinical inspection; Tele-dermatology applications in skin cancer diagnosis; Enhancing skin cancer diagnosis with dermoscopy; Mole Mapping for management of pigmented skin lesions; Temporal image comparison (Serial Imaging) in assessing pigmented lesions; Multispectral digital skin lesion imaging and analysis; Using reflectance confocal microscopy in skin cancer diagnosis; Optical Coherence Tomography in the diagnosis of skin cancer; Electrical impedance spectroscopy in skin cancer diagnosis; The use of Raman Spectroscopy to detect and diagnose skin cancer; Applying high frequency ultrasound in the diagnosis of skin cancer; Proteomic mass spectrometery imaging for skin cancer diagnosis; Assessing skin cancer using epidermal genetic information retrieved by tape stripping; Smartphone-based applications for skin monitoring and melanoma detection; Detection of aberrations in cellular DNA in diagnosis and assessment of skin cancer; Assessing genetic expression profiles in melanoma diagnosis; Assessing genetic expression profiles in melanoma prognosis; and Integrating skin cancer related technologies into clinical practice.

This book discusses the main stem cell niches under distinct pathophysiological conditions. The role of tissue microenvironments in stem cell regulation, as well as modern methodologies and new techniques for the identification and characterization of stem cell niches, are discussed by leading experts in the field. Chapters describe the major components of various stem cell microenvironments, such as cellular components, soluble factors, cell-cell interactions, extra-cellular matrix proteins, and physical forces. Stem Cell Microenvironments and Beyond is part of the highly successful Advances in Experimental Medicine and Biology series. It is essential reading for graduate students and researchers in the field of stem cells or cell biology as well as clinicians.

This issue of Surgical Oncology Clinics of North America, guest edited by Dr. Kelly Hunt, is devoted to Breast Cancer. Dr. Hunt has assembled expert authors to review the following topics: Tomosynthesis in breast cancer imaging: how does it fit into preoperative evaluation and surveillance?; Lobular breast cancer: different disease, different algorithms?; Hypofractionated radiation therapy in breast conserving therapy; Oncoplastic breast reconstruction: should all patients be considered?; Neoadjuvant endocrine therapy: who benefits most?; Breast cancer disparities: how can we leverage genomics to improve outcomes?; Anatomy and breast cancer staging: is it still relevant?; When does atypical ductal hyperplasia require surgical intervention?; Surgical intervention for lymphedema; Are there alternative strategies in the local management of DCIS?; Genetic testing and genetic counseling: what is standard of care?; Molecular subtypes and local-regional control of breast cancer; Intraoperative margin assessment in breast cancer management; Triple negative breast cancer: who should receive neoadjuvant chemotherapy?; and more!

Completely dedicated to the biomedical applications of metal nanoparticles, this book covers the different toxicity problems found in healthcare situations and also provides comprehensive info on the use of metal nanoparticles in treating various diseases. Metal Nanoparticles in Pharma is the first edited volume to set up the discussion for a clinical setting and to target a pharmaceutical audience of academic and industry-based researchers.

Your complete resource for handling the physical and emotional effects of breast cancer treatments. At the time of diagnosis, breast cancer patients are faced with many overwhelming decisions about possible treatments. Living with Breast Cancer provides you with an overview of what to expect from testing and treatment, which cancer specialists you may need to see, and common terms to use to help communicate your needs to your team. This empathetic resource full of relatable stories teaches patients and caregivers how to ask the right questions to get the best possible care. The authors explain how to minimize the symptoms and side effects of treatment and outline coping strategies to deal with the stress of breast cancer treatment, including the changes in your body from cancer and its therapies. The book helps readers * make sense of their diagnosis * set goals and prepare for treatment * understand the different types of therapies, tests, and scans * manage the symptoms and side effects of treatment, such as nausea, fatigue, shortness of breath, weight fluctuations, and depression * learn what medications and lifestyle modifications can help with symptoms * live and cope with progressive cancer Living with Breast Cancer is your definitive resource for handling the physical and emotional effects of breast cancer and treatment.

Selenium and Selenoproteins in Cancer, Volume 136, the latest release in the Advances in Cancer Research series, provides invaluable information on the fast-moving field of cancer research. This updated volume includes chapters on The epidemiology of selenium and human cancer, Selenium, epigenetics and cancer, Selenium status and cancer risk, Nutritional aspects of selenium and breast cancer risk: focus on cellular and molecular mechanisms, Selenoproteins in tumorigenesis and cancer progression, Selenoproteins and metastasis, The tumor microenvironment and inflammatory factors, and Selenium-dependent glutathione peroxidases during tumor development. This new release in the series presents original reviews on research regarding the prevention and treatment of cancer with selenium.

The complexity of cancer demands an integrated approach from both a cancer biology standpoint and a pharmaceutical basis to understand the different anticancer modalities. Current research has been focused on conventional and newer anticancer modalities, recent discoveries in cancer research, and also the advancements in cancer treatment. There is a current need for more research on the advances in cancer therapeutics that bridge the gap between basic research (pharmaceutical drug development processes, regulatory issues, and translational experimentation) and clinical application. Recent promising discoveries such as immunotherapies, promising therapies undergoing clinical trials, synthetic lethality, carbon beam radiation, and other exciting targeted therapies are being studied to improve and advance the studies of modern cancer treatment. The Handbook of Research on Advancements in Cancer Therapeutics serves as a comprehensive guide in modern cancer treatment by combining and merging the knowledge from both cancer biology and the pharmacology of anticancer modalities. The chapters come from multi-disciplinary backgrounds, including scientists and clinicians from both academia and various industries, to discuss nascent personalized therapies and big data-driven cancer treatment. While highlighting topic areas that include cancer prevention, cancer therapeutics, and cancer treatments through the lenses of technology, medicine/drugs, and alternate therapies, this book is ideally intended for oncologists, radiation oncologists, surgical oncologists, and cancer biologists, along with practitioners, stakeholders, researchers, academicians, and students who are interested in understanding the most fundamental aspects of cancer and the available therapeutic opportunities.

This issue of Hematology/Oncology Clinics will focus on The Treatment of Myeloid Malignancies with Kinase Inhibitors. Articles will focus on: Targeting aberrant signaling in myeloid malignancies: promise versus reality; The development and use of imatinib for the treatment of chronic myelogenous leukemia; Mechanisms of resistance to ABL kinase inhibition in CML and the development of next generation ABL kinase inhibitors; Tyrosine kinase inhibitors in the treatment of systemic mastocytosis and hypereosinophilic syndrome; The development and use of JAK2 inhibitors for the treatment of myeloproliferative neoplasms (MPN); Mechanisms of resistance to JAK2 inhibitors in MPN; Kinase inhibitor screening in myeloid malignancies; and more!

This issue of Hematology/Oncology Clinics, edited by Drs. John Perkins and and Jonathan Davis, focuses on emergencies related to Hematology/Oncology and covers topics such as: Oncologic Mechanical Emergencies, Neutropenic Fever, Oncologic Metabolic Emergencies, Acute Leukemias, Pediatric Oncologic Emergencies, Chemotherapeutic Medications and their Emergent Complications, Anemia, Thrombotic Microangiopathies (TTP, HUS, HELLP), Congenital Bleeding Disorders, Acquired Bleeding Disorders and Antithrombotic agents, Sickle Cell Disease, and more!

This volume will outline how to recreate the tumor microenvironment, to culture primary tumors without the need for developmental priming factors, and to deliver targeted therapeutics in a manner that recapitulates pharmacokinetics in vivo. Much of what may be learned from this volume will aid in understanding many aspects of the enhanced study of tumor cell biology in a physiologic context, open new avenues for drug screening and biomarker development, and accelerate the preclinical evaluation of novel personalized medicine strategies for patients in real time.